← Scroll for more →
Cardio Diagnostics Holdings, Inc. (CDIO)
In Vitro & In Vivo Diagnostic Substances
Latest Price
$1.90
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.51
P/B Ratio
0.76
Institutional Ownership
6.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 49.2K | -- | 1.66% | +33.9K | 2026-06-30 |
| BlackRock, Inc. | 34.7K | -- | 1.17% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 26.2K | -- | 0.89% | -5.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 20.2K | -- | 0.68% | -- | 2026-06-30 |
| Citadel Advisors LLC | 19.1K | -- | 0.64% | +8.2K | 2026-06-30 |
| XTX Topco Ltd | 16.1K | -- | 0.54% | -- | 2026-06-30 |
| Jane Street Group, LLC | 11.9K | -- | 0.40% | -69.3K | 2026-06-30 |
| State Street Corp | 10.1K | -- | 0.34% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 2.8K | -- | 0.10% | -1.1K | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 1.8K | -- | 0.06% | -383 | 2026-06-30 |